QDEL

Quidel Corporation [QDEL] Stock Forecast

Q: What is Quidel Corporation stock symbol ?

Quidel Corporation is a US stock, located in San diego of Ca and trading under the symbol QDEL

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?

QDEL Stock Summary

EPS has been increasing for the past 3 quarters (Quarter statements)

EPS has increased from the previous quarter and is now positive. (Quarter statements)

In the last year, shareholders have seen their holdings diluted. Dilution over past year is 57.38%

Earnings are expected to fall -100% next year

EPS has been decreasing for the past 3 years (Yearly statements)

QDEL has less than 1 year of cash runway

An RSI reading of 30 or below indicates an oversold or undervalued condition.

Top 10 Correlated ETFs

QDEL

Top 10 Correlated Stocks

QDEL

In the News

QDEL Financial details

Company Rating

Strong Buy

Market Cap

2.82B

Income

-10.1M

Revenue

Book val./share

74.83

Cash/share

2.5

Dividend

Dividend %

Employees

7.1K

Optionable

Shortable

Yes

Earnings

04 May 2024

P/E

366.92

Forward P/E

PEG

-36.09

P/S

1.55

P/B

0.98

P/C

15.65

P/FCF

25.46

Quick Ratio

0.61

Current Ratio

1.59

Debt / Equity

0.49

LT Debt / Equity

0.45

EPS (TTM)

-0.16

EPS next Y

EPS next Q

EPS this Y

-101.55%

EPS next Y

EPS next 5Y

EPS last 5Y

NAN%

Revenue last 5Y

41.12%

Revenue Q/Q

-0.19%

EPS Q/Q

-152.63%

SMA20

-14.58%

SMA50

-39.71%

SMA100

-39.71%

Inst Own

67.28%

Inst Trans

0.72%

ROA

ROE

ROC

0.02%

Gross Margin

50%

Oper. Margin

Profit Margin

Payout

Shs Outstand

Shs Float

Target Price

52W Range

41.75-98.67

52W High

-60.08%

52W Low

-4.59%

RSI

Rel Volume

0.5

Avg Volume

1.09M

Volume

547.6K

Perf Week

-8.98%

Perf Month

-15.43%

Perf Quarter

-35.85%

Perf Half Y

-43.58%

Beta

0.12

Volatility

1.46%, 3.36%

Prev Close

2.25%

Price

39.12

Change

1.27%

QDEL Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2023-12-31

Metric	2019-12-31	2020-12-31	2021-12-31	2023-01-01	2023-12-31
	2.02K	2.02K	2.02K	2.02K	2.02K
Revenue per share	13.09	39.45	40.37	57.5	44.81
Net income per share	1.78	19.24	16.74	9.66	-0.15
Operating cash flow per share	3.29	14.95	19.15	15.59	4.19
Free cash flow per share	2.62	13.41	12.2	13.11	1.06
Cash per share	1.29	11.63	19.69	6.07	2.5
Book value per share	13.7	31.64	45.85	86.88	74.94
Tangible book value per share	1.83	20.73	35.5	-11.73	-6.29
Share holders equity per share	13.7	31.64	45.85	86.88	74.94
Interest debt per share	3.11	2.8	3.43	51.06	38.3
Market cap	3.07B	7.57B	5.68B	4.87B	4.92B
Enterprise value	3.13B	7.19B	5.02B	7.4B	7.42B
P/E ratio	42.04	9.34	8.07	8.87	-487.44
Price to sales ratio	5.73	4.55	3.34	1.49	1.64
POCF ratio	22.8	12.02	7.05	5.5	17.57
PFCF ratio	28.58	13.4	11.07	6.54	69.44
P/B Ratio	5.48	5.68	2.94	0.99	0.98
PTB ratio	5.48	5.68	2.94	0.99	0.98
EV to sales	5.84	4.32	2.95	2.27	2.48
Enterprise value over EBITDA	29.94	6.75	5.48	6.7	10.54
EV to operating cash flow	23.24	11.41	6.22	8.36	26.48
EV to free cash flow	29.14	12.72	9.77	9.94	104.63
Earnings yield	0.02	0.11	0.12	0.11	0
Free cash flow yield	0.03	0.07	0.09	0.15	0.01
Debt to equity	0.2	0.08	0.07	0.57	0.49
Debt to assets	0.12	0.06	0.06	0.32	0.29
Net debt to EBITDA	0.57	-0.36	-0.73	2.29	3.55
Current ratio	1.77	3.39	4.45	1.56	1.57
Interest coverage	3.56	110.19	158.79	11.15	2.1
Income quality	1.84	0.78	1.14	1.61	-27.74
Dividend Yield	0	0	0	0	0
Payout ratio	0	0	0	0	0
Sales general and administrative to revenue	0.1	0.04	0.05	0.18	0
Research and developement to revenue	0.1	0.05	0.06	0.06	0.08
Intangibles to total assets	0.53	0.25	0.18	0.63	0.63
Capex to operating cash flow	-0.2	-0.1	-0.36	-0.16	-0.75
Capex to revenue	-0.05	-0.04	-0.17	-0.04	-0.07
Capex to depreciation	-0.53	-1.32	-5.38	-0.5	-0.46
Stock based compensation to revenue	0.02	0.01	0.01	0.01	0.02
Graham number	23.46	117.02	131.4	137.42	15.97
ROIC	0.06	0.53	0.32	0.08	0.01
Return on tangible assets	0.17	0.57	0.35	0.17	0
Graham Net	-4.66	9.62	17.16	-52.35	-40.94
Working capital	96.34M	805.44M	1.12B	568.1M	476.7M
Tangible asset value	74.69M	873.24M	1.49B	-666M	-420.4M
Net current asset value	-128.82M	603.94M	939.3M	-2.35B	-2.25B
Invested capital	0.2	0.08	0.07	0.57	0.49
Average receivables	90.9M	317.04M	461.51M	423.87M	471.15M
Average payables	25.94M	56.51M	93.9M	192.4M	289.05M
Average inventory	62.73M	85.94M	156.28M	361.43M	550.95M
Days sales outstanding	71.59	116.24	84.63	50.73	59.55
Days payables outstanding	45.52	100.72	86.62	77.75	62.92
Days of inventory on hand	99.03	132.78	169.64	143.83	123.32
Receivables turnover	5.1	3.14	4.31	7.2	6.13
Payables turnover	8.02	3.62	4.21	4.69	5.8
Inventory turnover	3.69	2.75	2.15	2.54	2.96
ROE	0.13	0.61	0.36	0.11	0
Capex per share	-0.67	-1.54	-6.96	-2.48	-3.13

Quarterly Fundamentals Overview

Last date of statement is 2023-12-31 for Q4

Metric	2023-01-01	2023-04-02	2023-07-02	2023-10-01	2023-12-31
	2.02K	2.02K	2.02K	2.02K	2.02K
Revenue per share	13.07	12.7	9.96	11.12	11.1
Net income per share	0.46	0.73	-0.8	-0.19	0.1
Operating cash flow per share	2.56	2.84	-0.46	0.62	1.2
Free cash flow per share	1.62	1.85	-1.23	-0.03	0.48
Cash per share	5.2	5.96	3.35	2.89	2.5
Book value per share	74.43	75.02	74.89	74.24	74.83
Tangible book value per share	-10.05	-8.61	-7.55	-6.77	-6.28
Share holders equity per share	74.43	75.02	74.89	74.24	74.83
Interest debt per share	43.13	42.15	40.92	40.08	37.03
Market cap	5.68B	5.97B	5.56B	4.86B	4.93B
Enterprise value	8.21B	8.39B	8.08B	7.36B	7.43B
P/E ratio	46.86	30.6	-26.13	-95.75	176.09
Price to sales ratio	6.56	7.06	8.36	6.54	6.64
POCF ratio	33.53	31.63	-181.74	117.21	61.33
PFCF ratio	52.74	48.61	-67.9	-2.56K	155.05
P/B Ratio	1.15	1.2	1.11	0.98	0.98
PTB ratio	1.15	1.2	1.11	0.98	0.98
EV to sales	9.48	9.92	12.15	9.89	10
Enterprise value over EBITDA	52.61	47.35	169.38	73.51	185.18
EV to operating cash flow	48.48	44.42	-264.04	177.31	92.36
EV to free cash flow	76.25	68.27	-98.65	-3.87K	233.51
Earnings yield	0.01	0.01	-0.01	0	0
Free cash flow yield	0.02	0.02	-0.01	0	0.01
Debt to equity	0.57	0.55	0.54	0.53	0.49
Debt to assets	0.32	0.32	0.32	0.31	0.29
Net debt to EBITDA	16.22	13.64	52.8	24.92	62.22
Current ratio	1.56	1.65	1.66	1.59	1.57
Interest coverage	2.49	2.71	-0.74	0.7	1.09
Income quality	5.59	3.87	0.58	-3.27	11.49
Dividend Yield	0	0	0	0	0
Payout ratio	0.02	0.19	-0.06	-0.04	1.86
Sales general and administrative to revenue	0.03	0	0	0	0
Research and developement to revenue	0.07	0.07	0.09	0.08	0.08
Intangibles to total assets	0.63	0.63	0.64	0.63	0.63
Capex to operating cash flow	-0.36	-0.35	1.68	-1.05	-0.6
Capex to revenue	-0.07	-0.08	-0.08	-0.06	-0.07
Capex to depreciation	-0.53	-0.58	-0.45	-0.38	-0.42
Stock based compensation to revenue	0.01	0.01	0	0.02	0.02
Graham number	27.66	35.17	36.63	17.81	13.27
ROIC	0.01	0.01	0	0	0
Return on tangible assets	0.01	0.02	-0.02	0	0
Graham Net	-44.85	-43.9	-42.93	-42.67	-40.88
Working capital	568.1M	591.1M	518.1M	511.3M	476.7M
Tangible asset value	-666M	-573.3M	-504.1M	-452.7M	-420.4M
Net current asset value	-2.35B	-2.29B	-2.24B	-2.2B	-2.25B
Invested capital	0.57	0.55	0.54	0.53	0.49
Average receivables	435.25M	364.35M	260.75M	288.95M	409.8M
Average payables	262.55M	262.4M	233.7M	239.45M	273.9M
Average inventory	530.15M	526.35M	535.4M	546.95M	564.75M
Days sales outstanding	47.14	29.23	33.38	40.06	59.19
Days payables outstanding	61.07	54.68	55.14	60.57	62.78
Days of inventory on hand	112.98	119.68	132.35	132.09	123.05
Receivables turnover	1.91	3.08	2.7	2.25	1.52
Payables turnover	1.47	1.65	1.63	1.49	1.43
Inventory turnover	0.8	0.75	0.68	0.68	0.73
ROE	0.01	0.01	-0.01	0	0
Capex per share	-0.93	-0.99	-0.77	-0.65	-0.73

QDEL Frequently Asked Questions

What is Quidel Corporation stock symbol ?

Quidel Corporation is a US stock , located in San diego of Ca and trading under the symbol QDEL

What is Quidel Corporation stock quote today ?

Quidel Corporation stock price is $39.12 today.

Is Quidel Corporation stock public?

Yes, Quidel Corporation is a publicly traded company.

Something similar

Top by Market Cap

Top Correlated ETFs

Top Correlated Stocks

Similar Market Cap

Company Profile

Volume Average 1.09M
Market Capitalization 2.82B
Employee 7.1K
CEO Mr. Michael S. Iskra
Headquarters San Diego,CA,US
IPO Date 1991-02-01
Website https://www.quidelortho.com

QuidelOrtho Corporation focuses on the development and manufacture of diagnostic testing technologies across the continuum of healthcare testing needs. The company operates through Labs, Transfusion Medicine, Point-of-Care, and Molecular Diagnostics business units. The Labs business unit provides clinical chemistry laboratory instruments and tests that measure target chemicals in bodily fluids for the evaluation of health and the clinical management of patients; immunoassay laboratory instruments and tests, which measure proteins as they act as antigens in the spread of disease, antibodies in the immune response spurred by disease, or markers of proper organ function and health; testing products to detect and monitor disease progression across a spectrum of therapeutic areas; and specialized diagnostic solutions. The Transfusion Medicine business unit offers immunohematology instruments and tests used for blood typing to ensure patient-donor compatibility in blood transfusions; and donor screening instruments and tests used for blood and plasma screening for infectious diseases. The Point-of-Care business unit provides tests to provide rapid results across a continuum of point-of-care settings. The Molecular Diagnostics business unit offers polymerase chain reaction thermocyclers; and analyzers and amplification systems. The company sells its products directly to end users through a direct sales force; and through a network of distributors for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, urgent care clinics, universities, retail clinics, pharmacies, wellness screening centers, blood banks, and donor centers, as well as for individual, non-professional, and over-the-counter use. It operates in North America, Europe, the Middle East, Africa, China, and internationally. The company was founded in 1979 and is headquartered in San Diego, California.